Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 01 Apr 2021 for Pandion Therapeutics, Inc., €2.8M.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
Edward D. Freedman: trading record in brief
All filings by Edward D. Freedman on record concern Pandion Therapeutics, Inc. Over a trading history stretching from 21 July 2020 to 1 April 2021, the count stands at 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 1 April 2021, the filings show a transaction worth €2.8M in Pandion Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Edward D. Freedman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
54,460 shares@ US$60.00100.0% of flowCommon StockSEC:0000899243-21-014459:0
2,348 sharesCommon StockSEC:0000899243-20-019854:0
2 of 2 declarations
